Pharmacokinetics of 4-aminopyridine derivatives in dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2009, Pages 485-491

  Olby, N J ^a   Smith, D T ^b   Humphrey, J ^a   Spinapolice, K ^a   Parke, N ^a   Mehta, P M ^a   Dise, D ^a   Papich, M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE DERIVATIVE; DIAZEPAM; N (4 PYRIDYL) ETHYL CARBAMATE; N (4 PYRIDYL) METHYL CARBAMATE; N (4 PYRIDYL) TERT BUTYL CARBAMATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG SAFETY; EXPERIMENTAL MODEL; FEMALE; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SEIZURE; SPINAL CORD; SPINAL CORD INJURY;

4-AMINOPYRIDINE; ADMINISTRATION, ORAL; ANIMALS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; POTASSIUM CHANNEL BLOCKERS;

CANIS FAMILIARIS; CAVIA;

EID: 70349103381     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01072.x     Document Type: Article

References (38)

1. Agoston, S., Bowman, W.C., Houwertjes, M.C., Rodger, I.W. Savage, A.O. (1982) Direct action of 4-aminopyridine on the contractility of a fast-contracting muscle in the cat. Clinical and Experimental Pharmacology and Physiology, 9, 21 34.
2. Blight, A.R. (1989) Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Research Bulletin, 22, 47 52.
3. Blight, A.R. Gruner, J.A. (1987) Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats. Journal of the Neurological Sciences, 82, 145 159.
4. Blight, A.R., Toombs, J.P., Bauer, M.S. Widmer, W.R. (1991) The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. Journal of Neurotrauma, 8, 103 119.
5. Bostock, H., Sherratt, R.M. Sears, T.A. (1978) Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials. Nature, 274, 385 387.
6. van der Bruggen, M.A., Huisman, H.B., Beckerman, H., Bertelsmann, F.W., Polman, C.H. Lankhorst, G.J. (2001) Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury. Journal of Neurology, 248, 665 671.
7. Chiu, S.Y. Ritchie, J.M. (1980) Potassium channels in nodal and internodal axonal membrane of mammalian myelinated fibres. Nature, 284, 170 171.
8. Davis, F.A., Stefoski, D. Rush, J. (1990) Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Annals of Neurology, 27, 186 192.
9. DeForge, D., Nymark, J., Lemaire, E., Gardner, S., Hunt, M., Martel, L., Curran, D. Barbeau, H. (2004) Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial. Spinal Cord, 42, 674 685.
10. Donovan, W.H., Halter, J.A., Graves, D.E., Blight, A.R., Calvillo, O., McCann, M.T., Sherwood, A.M., Castillo, T., Parsons, K.C. Strayer, J.R. (2000) Intravenous infusion of 4-AP in chronic spinal cord injured subjects. Spinal Cord, 38, 7 15.
11. Gabrielsson, J. Weiner, D. (2000) In: Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Application, 3rd edn. Swedish Pharmaceutical Press, Stockholm.
12. Gibaldi, M. Perrier, D. (1982) In: Pharmacokinetics. Informa Healthcare, New York, NY.
13. Goodman, A.D., Cohen, J.A., Cross, A., Vollmer, T., Rizzo, M., Cohen, R., Marinucci, L. Blight, A.R. (2007) Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Multi Sclerosis, 13, 357 368.
14. Goodman, A.D., Brown, T.R., Cohen, J.A., Krupp, L.B., Schapiro, R., Schwid, S.R., Cohen, R., Marinucci, L.N. Blight, A.R. (2008) Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology, 71, 1134 1141.
15. Goodman, A.D., Brown, T.R., Krupp, L.B., Schapiro, R.T., Schwid, S.R., Cohen, R., Marinucci, L.N., Blight, A.R. on behalf of the Fampridine MS-F203 Investigators Sustained-release oral fampridine in multiple sclerosis 2009) A randomised, double-blind, controlled trial. Lancet, 373, 732 738.
16. Grijalva, I., Guizar-Sahagun, G., Castaneda-Hernandez, G., Mino, D., Maldonado-Julian, H., Vidal-Cantu, G., Ibarra, A., Serra, O., Salgado-Ceballos, H. Arenas-Hernandez, R. (2003) Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial. Pharmacotherapy, 23, 823 834.
17. Gruner, J.A. Yee, A.K. (1999) 4-Aminopyridine enhances motor evoked potentials following graded spinal cord compression injury in rats. Brain Research, 816, 446 456.
18. Halter, J.A., Blight, A.R., Donovan, W.H. Calvillo, O. (2000) Intrathecal administration of 4-aminopyridine in chronic spinal injured patients. Spinal Cord, 38, 728 732.
19. Hansebout, R.R., Blight, A.R., Fawcett, S. Reddy, K. (1993) 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. Journal of Neurotrauma, 10, 1 18.
20. Hayes, K.C. (2004) The use of 4-aminopyridine (fampridine) in demyelinating disorders. CNS Drug Reviews, 10, 295 316.
21. Hayes, K.C. (2007) Fampridine-SR for multiple sclerosis and spinal cord injury. Expert Review of Neurotherapeutics, 7, 453 461.
22. Hayes, K.C., Blight, A.R., Potter, P.J., Allatt, R.D., Hsieh, J.T., Wolfe, D.L., Lam, S. Hamilton, J.T. (1993) Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Paraplegia, 31, 216 224.
23. Hayes, K.C., Potter, P.J., Wolfe, D.L., Hsieh, J.T., Delaney, G.A. Blight, A.R. (1994) 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. Journal of Neurotrauma, 11, 433 446.
24. Jankowska, E., Lundberg, A., Rudomin, P. Sykova, E. (1982) Effects of 4-aminopyridine on synaptic transmission in the cat spinal cord. Brain Research, 240, 117 129.
25. McBride, J.M., Smith, D.T., Byrn, S.R., Borgens, R.B. Shi, R. (2006) Dose responses of three 4-aminopyridine derivatives on axonal conduction in spinal cord trauma. European Journal of Pharmaceutical Sciences, 27, 237 242.
26. McBride, J.M., Smith, D.T., Byrn, S.R., Borgens, R.B. Shi, R. (2007) 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury. Neuroscience, 148, 44 52.
27. Nashmi, R. Fehlings, M.G. (2001) Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Research. Brain Research Reviews, 38, 165 191.
28. Potter, P.J., Hayes, K.C., Hsieh, J.T., Delaney, G.A. Segal, J.L. (1998) Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases. Spinal Cord, 36, 147 155.
29. Pratt, K., Toombs, J.P., Widmer, W.R. Borgens, R.B. (1995) Plasma and cerebrospinal fluid concentrations of 4-aminopyridine following intravenous injection and metered intrathecal delivery in canines. Journal of Neurotrauma, 12, 23 39.
30. Qiao, J., Hayes, K.C., Hsieh, J.T., Potter, P.J. Delaney, G.A. (1997) Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury. Journal of Neurotrauma, 14, 135 149.
31. Schwid, S.R., Petrie, M.D., McDermott, M.P., Tierney, D.S., Mason, D.H. Goodman, A.D. (1997) Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology, 48, 817 821.
32. Sherratt, R.M., Bostock, H. Sears, T.A. (1980) Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature, 283, 570 572.
33. Shi, R. Blight, A.R. (1997) Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience, 77, 553 562.
34. Smith, K.J., Felts, P.A. John, G.R. (2000) Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. Brain, 123 (Pt 1 171 184.
35. Smith, D.T., Shi, R., Borgens, R.B., McBride, J.M., Jackson, K. Byrn, S.R. (2005) Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. European Journal of Medicinal Chemistry, 40, 908 917.
36. Stefoski, D., Davis, F.A., Faut, M. Schauf, C.L. (1987) 4-Aminopyridine improves clinical signs in multiple sclerosis. Annals of Neurology, 21, 71 77.
37. Stork, C.M. Hoffman, R.S. (1994) Characterization of 4-aminopyridine in overdose. Journal of Toxicology. Clinical Toxicology, 32, 583 587.
38. The United States Pharmacopeia, Thirty-Second Revision and the National Formulary, Twenty-Seventh Edition (USP-32NF27) 2009) General Chapter <621>. The United States Pharmacopeial Convention, Rockville, MD.